Skip to main content
. 2018 Oct 19;25(1):1756–1765. doi: 10.1080/10717544.2018.1507061

Table 2.

Characterization of B-LNCs (n = 6) and SFN-LNCs (n = 17).

Sample Size (nm) PDI Zeta potential (mV) Drug payload (mg/g) Encapsulation efficiency (%)
B-LNCs 49 ± 1 0.11 ± 0.01 −7.9 ± 0.4
SFN-LNCs 54 ± 1 0.15 ± 0.01 −7.8 ± 0.6 2.11 ± 0.03 105 ± 1